Evidence map›Paper›PMID 36481665›Full record

ArticleNature communications2022

Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.

Wei Jiao, Gurnit Atwal, Paz Polak, Rosa Karlic, Edwin Cuppen, PCAWG Tumor Subtypes and Clinical Translation Working Group, Alexandra Danyi, Jeroen de Ridder, Carla van Herpen, Martijn P Lolkema and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Wei Jiao *Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
Gurnit Atwal *Computational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-2817-3117
Paz Polak *Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-2153-4488
Rosa KarlicBioinformatics Group, Division of Molecular Biology, Department of Biology, Faculty of Science, University of Zagreb, Horvatovac 102a, Zagreb, Croatia.ORCID http://orcid.org/0000-0002-1291-2897
Edwin CuppenHartwig Medical Foundation, Science Park 408, Amsterdam, The Netherlands.
PCAWG Tumor Subtypes and Clinical Translation Working Group
Alexandra DanyiCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Jeroen de RidderCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-0828-3477
Carla van HerpenRadboud University Medical Center, Nijmegen, The Netherlands.
Martijn P LolkemaDepartment of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-0466-2928
Neeltje SteeghsDepartment of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Gad GetzBroad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-0936-0753
Quaid D MorrisVector Institute, Toronto, ON, Canada.ORCID http://orcid.org/0000-0002-2760-6999
Lincoln D SteinComputational Biology Program, Ontario Institute for Cancer Research, Toronto, ON, Canada. lincoln.stein@gmail.com.
PCAWG Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36481665
PMCPMC9732335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.